Monday, February 20, 2017 1:49:48 PM
I'm not saying that it wouldn't be a good move but I'd rather do something else with my money.
First, I don't think this dip will be severe but we'll have to wait for the CC to see what other surprises are ahead.
Secondly, If the FDA were to grant anyone else approval while Pfizer is fixing the light bulbs this stock will be under tremendous pressure.
Eventually, when approval is granted, if a second company is approved at the same time the stock is stuck.
I don't see the +'s outweighing the -'s to be worthwhile.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM